SEC Form 4 · accession 0001493152-26-036231
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kameel D. Farag
Officer — Interim CFO
Period of report
Jul 16, 2026
Accepted (ET)
Aug 5, 2026 · 6:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary SharesF1 | Jul 16, 2026 | A | 1,130 | $11.50 | A | 21,581 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on August 16, 2026.